Media Coverage (Cancers)

Common immune response is found to be protective across many diseases

ISB researchers offer promising avenues for exploring multi-disease therapeutic strategies.

Posted:
Medical Xpress
Common immune response is found to be protective across many diseases

T Cell Receptor Sequences Are the Dominant Factor Contributing to the Phenotype of CD8+ T Cells with Specificities Against Immunogenic Viral Antigens

ISB President Dr. Jim Heath talked with Science in Seattle in a wide-ranging interview that touched on his paper in Cell Reports showing how T-cell receptors form, his transition from chemistry to biology, challenges facing life scientists, and more.

Posted:
Science in Seattle
T Cell Receptor Sequences Are the Dominant Factor Contributing to the Phenotype of CD8+ T Cells with Specificities Against Immunogenic Viral Antigens

Is AI the Cancer-Fighting Tool We’ve Been Waiting For?

As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against cancer. ISB President Dr. Jim Heath was interviewed for this extensively reported feature story for Newsweek Magazine.

Posted:
Newsweek
Is AI the Cancer-Fighting Tool We’ve Been Waiting For?

Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset

ISB and NED Biosystems will collaborate on an intriguing clinical trial that aims to use a cocktail of several marketed medications at low doses to reverse cancer’s onset or regrowth. ISB Co-founder Lee Hood and NED Biosystems founder and CEO Rebecca Lambert announced the deal.

Posted:
Inside Precision Medicine
Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset

T Cell Discovery Unlocks Potential for Crafting Tailored Immune Responses

This story published by Inside Precision Medicine covers ISB research showing that the different disease-fighting functions of distinct T cells are determined by the genetically encoded T-cell receptor (TCR) sequence that are unique to those cells. The findings are promising for developing custom immune responses to specific antigens.

Posted:
Inside Precision Medicine
T Cell Discovery Unlocks Potential for Crafting Tailored Immune Responses

New Potential for Immunotherapy: Scientists Shed Light on How Immune Cells Respond to Cancer Cells

Work by ISB President Jim Heath and collaborators at UCLA, PACT Pharma and beyond identified and analyzed the process by which immune cells “see” and react to cancer cells, providing valuable insights into why certain treatments may work for some patients but not for others.

Posted:
SciTechDaily
New Potential for Immunotherapy: Scientists Shed Light on How Immune Cells Respond to Cancer Cells

The AI will see you now

The Wall Street Journal published an essay adapted from “The Age of Scientific Wellness,” a book authored by Drs. Lee Hood and Nathan Price.

Posted:
The Wall Street Journal
The AI will see you now

Research reveals how fatty acids are absorbed by singular cells

This ANI news story highlights research by ISB’s Wei Lab and UC Riverside in how fatty acids are absorbed by single cells, providing new insights into cancer biology.

Posted:
ANI
Research reveals how fatty acids are absorbed by singular cells
1 2